The rest of this story is for members
The rest is for members
The story continues: the full timeline, the transaction ranges, and the names the forms carry.
Premium comes through the Telegram channel. Already have a code? Sign in to activate it.
Premium
CLYM
Deerfield healthcare fund acquired over 5% of Climb Bio
Following price declines after the publication of trial data, investment fund Deerfield seized the opportunity and built a new position in Climb Bio.
Other Stories
Unusual insider purchase at Flagstar Bank
PremiumInsidersFLG26m ago2 min read
Who is John Arnold and why is he increasing his stake in Fervo Energy?
PremiumInsidersFRVO3h ago3 min read
Morning review: Oil plummets and futures are in the green ahead of Apple and Palantir earnings
PremiumMarket OverviewAAPL4h ago2 min read